Overview

A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers

Status:
Completed

Trial end date:
2020-02-11

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to evaluate the effects of food and pH on the relative bioavailability (BA) of the tablet formulation of BMS-986165 in healthy volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

BMS-986165
Famotidine